Table 1. Patient characteristics at baseline.

Characteristics	No. of patients	%
Total enrolled/evaluable	37/36	—
Age (years)
Median	44
Range	30–68
Menopausal status
Premenopausal	25	69
Postmenopausal	11	31
Clinical tumour size
T2	22	61
T3	9	25
T4	5	14
Clinical nodal status
N0	11	31
N1	22	61
N2	1	3
N3	2	5
PgR status
PgR negative/low	6	17
PgR positivea	30	83
Ki67
<20%	14	39
⩾20%	22	61
Nuclear grade
1	1	3
2	27	75
3	6	17
Unknown	2	5

PgR=progesterone receptor.

^aPositive: ⩾10%.